Consensus on Antiretroviral Treatment. Ministry of Health Malaysia, Academy of Medicine of Malaysia and Malaysian Society of Infectious Diseases and Chemotherapy (2001)

Consensus on Antiretroviral Treatment. Ministry of Health Malaysia, Academy of Medicine of Malaysia and Malaysian Society of Infectious Diseases and Chemotherapy (2001) Recent advances in the knowledge of HIV pathogenesis, the rapid development of potent antiretroviral agents coupled with the availability of more sensitive laboratory tools such as the viral load assays have greatly altered the management of HIV-infected patients. Guidelines for the use of the increasingly complex armamentarium of antiretroviral agents, including new classes of drugs, have been published in many parts of the developed world.

Download this publication

HIV Prevention Needs and Successes: A Tale of Three Countries. UNAIDS (2001)

HIV Prevention Needs and Successes: A Tale of Three Countries. UNAIDS (2001) HIV prevention is necessary even in the presence of advanced antiretroviral thera- pies. The cost of the drugs, the limited access to these therapies (and to drugs for oppor- tunistic infections in general), and the development of drug resistance remain important issues, even in the wealthiest countries. In many areas, prevention programmes and information need to be strengthened as many people mistakenly view antiretroviral thera- pies as a cure and therefore continue to engage in risky behaviour.

Download this publication

HIV/AIDS Prevention and Care Project: Project Design Document. AusAID (2000)

HIV/AIDS Prevention and Care Project: Project Design Document. AusAID (2000) In 1999 the Government of the Peoples Republic of China (GoPRC) in Xinjiang-Uygur Autonomous Region (Xinjiang) submitted a project proposal, Project Proposal on HIV/AIDS Prevention and Control in Xinjiang Uygur Autonomous Region, to the Australian Government (GoA) through the GoPRC Ministry of Foreign Trade and Economic Cooperation (MoFTEC) for funding through the Australian Agency for International Development (AusAID). The proposal was in response to Xinjiang having the second highest number of people with HIV/AIDS in PRC and the highest rate of increase.

Download this publication

HIV-Related Opportunistic Diseases - UNAIDS Technical Update. UNAIDS (1998)

HIV-Related Opportunistic Diseases - UNAIDS Technical Update. UNAIDS (1998) Opportunistic diseases in a person with HIV are the products of two things: the person’s lack of immune defences caused by the virus, and the presence of microbes and other pathogens in our everyday environment.

Download this publication

Global Forecasts of Antiretroviral Demand for 2014–2018, Projection Modelling of New Antitretroviral Formulations for 2015–2024 and Update on Hepatitis B and C. WHO. (2015)

immage

The World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) Secretariat organize an annual meeting with pharmaceutical companies and stakeholders to discuss antiretroviral (ARV) drug demand forecasts for adults and children.

 

The March 2015 meeting went beyond the usual three- year forecast by including a model of new ARVs that will be needed up to 2024. For the first time this year, the meeting also included a discussion on hepatitis B and C medicines. 


Keywords: HIV infections, therapy, drug, ARV, children


Download Publication

HIV Self-testing: What You Need to Know. UNAIDS. (2018)

immage

People can test wherever and whenever they want. HIV self-testing empowers people to find out their HIV status wherever and whenever they want. Since it is easy, quick and private, people may be encouraged to take a test earlier than they would if they had to visit a health facility, potentially bringing an earlier diagnosis. Any HIV-positive result must, however, be followed up with a second test by a health-care provider to confirm the result and get linked to appropriate prevention, treatment and care.


Keywords: HIV, self-testing, privacy

 

Download Infographics

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_GAP_progress_report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Sep
17
(17 Sep - 17 Sep)
Oct
11
Nov
14